Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma

BACKGROUND: Androgen deprivation therapy (ADT) is widely used in the treatment of testosterone-dependent prostate carcinomas. ADT often increases plasma LDL and HDL cholesterol and triglycerides. The aim was to test whether ADT changes the transfer of lipids to HDL, an important aspect of this metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Albuquerque, Cicero P., Freitas, Fatima R., Martinelli, Ana Elisa M., Lima, Josefa H., Coelho, Rafael F., Serrano Jr., Carlos V., Nahas, Willian C., Kalil Filho, Roberto, Maranhão, Raul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285573/
https://www.ncbi.nlm.nih.gov/pubmed/32522195
http://dx.doi.org/10.1186/s12944-020-01305-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285573/
https://www.ncbi.nlm.nih.gov/pubmed/32522195
http://dx.doi.org/10.1186/s12944-020-01305-8

Ejemplares similares